Yıl: 2018 Cilt: 38 Sayı: 2 Sayfa Aralığı: 161 - 170 Metin Dili: İngilizce DOI: 10.5336/medsci.2018-59993 İndeks Tarihi: 09-01-2019

Alternative Methods to Animal Experiments

Öz:
In research based sciences ''Alternatives to Animals'' can be stated as testing methods which can replace partial or absolute use of animals; and this field not merely rely on the replacement of tests but the development and implementation of those testing methods to avoid the use of live animals also comes under this section. There are two major alternatives to in-vivo animal testing: The first ones are in vitro cell culture techniques, the seconds ones are in silico computer simulations. Microdosing is one of the other alternative options to study the basic behaviour of drugs by using lower than expected doses to produce whole body effects in volunteer human beings. Microfluidic chips are getting key interest in alternatives; because of the provision of more complex information as compare to other in vitro tests. Imaging studies like computed tomography (CT), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), positron emission tomography (PET) and single photon emission computed tomography (SPECT) are playing unmatchable role while studying some organ systems of the body. Non-Animal Method Database resources are gaining much more popularity since the concept of alternative to animals is culminating all around the world. Because of the advancement in molecular and cellular biology experiments; a lot of information is being generated and stored for in vitro and in silico experiments for better scientific understandings of experimental drugs on body systems. Three Rs (3Rs) Replacement, Reduction and Refinement of Russell and Burch are like guiding principles for more ethical use of animals in testing. In this review, main alternative methods to animal studies are summarized.
Anahtar Kelime:

Konular: Genel ve Dahili Tıp

Hayvan Deneyleri İçin Alternatif Yöntemler

Öz:
Hayvanlar üzerinde yapılan bilimsel araştırmalarda, araştırmanın bir parçası ya da tamamının yerine geçebilecek test yöntemleri gittikçe önem kazanmaktadır. Bu alanda yalnızca hayvan deneyleri yerine geçebilecek yöntemler değil, ayrıca hayvanların bu araştırmalarda kullanımından kaçınmak için yöntemlerin geliştirilmesi ve uygulanması da yer almaktadır. In vivo hayvan deneyleri için başlıca iki alternatif vardır. Bunlardan ilki in vitro hücre kültürü teknikleri, ikincisi in silico bilgisayar simülasyonlarıdır. Mikro doz tekniği ilaçların temel özelliklerini gönüllü bireylerde vücuttaki meydana getirmiş olduğu etkileri düşük dozda ortaya koyan alternatif bir diğer yöntemdir. Mikro-akışkan çip tekniği diğer yöntemlere kıyasla daha detaylı veriler sunması nedeni ile giderek önem kazanan alternatif bir yöntemdir. Bilgisayarlı tomografi (BT), manyetik rezonans görüntüleme (MR), fonksiyonel manyetik rezonans (fMR), pozitron emisyon tomografi (PET), tek foton emisyon bilgisayarlı tomografi (SPECT) gibi görüntüleme yöntemleri vücutta bazı sistemlerin incelenmesinde eşsiz rol oynarlar. Hayvansal olmayan yöntem veri tabanları dünya çapında hayvan deneylerine alternatif olma açısından giderek popülerlik kazanmaktadır. Moleküler ve hücresel biyoloji deneylerindeki gelişmeler sayesinde, in vitro ve in silico deneyler ile vücut sistemlerinde ilaç denemelerinin bilimsel olarak daha iyi anlaşılması için daha fazla bilgi elde edilip, saklanmaktadır. Russel ve Burch tarafından sunulan 3R kuralı yerine koyma (replacement), azaltma (reduction) ve hayvan refahı (refinement) ilkeleri bilimsel amaçlı deneylerde hayvanların daha etik kullanımına ilişkin rehber niteliği taşımaktadır. Bu derlemede hayvan deneylerine alternatif başlıca metotlar sunulmuştur.
Anahtar Kelime:

Konular: Genel ve Dahili Tıp
Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • 67. Piersma AH, Genschow E, Verhoef A, Spanjersberg MQ, Brown NA, Brady M, et al. Validation of the postimplantation rat whole-embryo culture test in the international ECVAM validation study on three in vitro embryotoxicity tests. Altern Lab Anim 2004;32(3):275307.
  • 66. Balls M, Blaauboer BJ, Fentem JH, Bruner L, Combes RD, Ekwall B, et al. Practical aspects of the validation of toxicity test procedures. The report and recommendations of ECVAM Workshop 5. Altern Lab Anim 1995;23:129-47.
  • 65. Huggins J. Alternatives to animal testing: research, trends, validation, regulatory acceptance. ALTEX 2003;20(Suppl 1):3-61.
  • 64. Balls M, Blaauboer B, Brusick D, Frazier J, Lamb D, Pemberton M, et al. Report and recommendations of the CAAT/ERGATT workshop on the validation of toxicity test procedures. Altern Lab Anim 1990;18:313-37.
  • 63. Goldsmith MR, Grulke CM, Chang DT, Transue TR, Little SB, Rabinowitz JR, et al. Dockscreen: a database in of silico biomolecular interactions to support computational toxicology. Dataset Pap Sci 2014;Article ID 421693.
  • 62. Comiskey D, Api AM, Barratt C, Daly EJ, Ellis G, McNamara C, et al. Novel database for exposure to fragrance ingredients in cosmetics and personal care products. Regul Toxicol Pharmacol 2015;72(3):660-72.
  • 61. Wright LL. Searching fee and non-fee toxicology information resources: an overview of selected databases. Toxicology 2001;157(1-2): 89-110.
  • 60. Laamanen I, Verbeek J, Franco G, Lehtola M, Luotamo M. Finding toxicological information: an approach for occupational health professionals. J Occup Med Toxicol 2008;3(1):18.
  • 59. Benigni R, Battistelli CL, Bossa C, Tcheremenskaia O, Crettaz P. New perspectives in toxicological information management, and the role of ISSTOX databases in assessing chemical mutagenicity and carcinogenicity. Mutagenesis 2013;28(4):401-9.
  • 58. Kandárová H, Letašiová S. Alternative methods in toxicology: pre-validated and validated methods. Interdiscip Toxicol 2011;4(3):107-13.
  • 57. Voigt K, Brüggemann R. Toxicology databases in the metadatabank of online databases. Toxicology 1995;100(1-3):225-40.
  • 56. U.S. Congress, Office of Technology Assessment. Alternatives to Animal Use in Research, Testing, and Education. OTA-BA-273. Washington, DC: U.S. Government Printing Office; 1986. p.433.
  • 55. Kim SW, Kim BH. A web-based alternative non-animal method database for safety cosmetic evaluations. Toxicol Res 2016;32(3): 259-67.
  • 54. Badyal DK, Modgill V, Kaur J. Computer simulation models are implementable as replacements for animal experiments. Altern Lab Anim 2009;37(2):191-5.
  • 53. Dewhurst DG, Hardcastle J, Hardcastle PT, Stuart E. Comparison of a computer simulation program and a traditional laboratory practical class for teaching the principles of intestinal absorption. Am J Physiol 1994;267(6 Pt 3):S95-104.
  • 52. Matthews EJ, Contrera JF. A new highly specific method for predicting the carcinogenic potential of pharmaceuticals in rodents using enhanced MCASE QSAR-ES software. Regul Toxicol Pharmacol 1998;28(3): 242-64.
  • 51. Knight A, Bailey J, Balcombe J. Animal carcinogenicity studies: 3. alternatives to the bioassay. Altern Lab Anim 2006;34(1):39-48.
  • 50. Reddy RN, Mutyala R, Aparoy P, Reddanna P, Reddy MR. Computer aided drug design approaches to develop cyclooxygenase based novel anti-inflammatory and anti-cancer drugs. Curr Pharm Des 2007;13(34):3505-17.
  • 49. Vedani A. [Computer-aided drug design: an alternative to animal testing in the pharmacological screening]. ALTEX 1991;8(1):39-60.
  • 48. Roncaglioni A, Benfenati E. In silico-aided predictionof biological properties of chemicals: oestrogen receptor-mediated effects. Chem Soc Rev 2008;37(3):441-50.
  • 47. Balaban RS, Hampshire VA. Challenges in small ani-mal noninvasive imaging. ILAR J 2001;42(3):248-62.
  • 46. Davis MA. Bioimaging of laboratory animals: the visual translation of molecular insights. ILAR J 2008;49(1):1-3.
  • 45. Hudson M. The welfare and scientific advantages of non-invasive imaging of animals used in biomedical re-search. Anim Welfare 2005;14(4):303-17.
  • 44. Tewari T, Mukherjee S. Microdosing: concept, appli-cation and relevance. Perspect Clin Res 2010;1(2):61-3.
  • 43. Zanni GR, Wick JY. Microdosing: the new pharmaco-kinetic paradigm? Consult Pharm 2006;21(10):757-76.
  • 42. Undale VR, Jagtap PN,Yadav AV, Sangamnerkar SK, Upasani CD, Bhosale AV. An isolated chicken ileum: alternative to laboratory animals for isolated tissue ex-perimentation. IOSR J Pharm 2012;2(5):39-45.
  • 41. Thasler WE, Schlott T, Kalkuhl A, Plän T, Irrgang B, Jauch KW, et al. Human tissue for in vitro research as an alternative to animal experiments: a charitable“hon-est broker” model to fulfil ethical and legalregulations and to protect research participants. Altern Lab Anim 2006;34(4):387-92.
  • 40. Bunney WE, Bunney BG, Vawter MP, Tomita H, Li J, Evans SJ, et al. Microarray technology: a review of new strategies to discover candidate vulnerability genesin psychiatric d isorders. Am J Ps ychiatry 2003;160(4):657-66.
  • 39. Prot JM, Leclerc E. The current status of alternatives to animal testing and predictive toxicology methodsusing liver micr ofluidic biochips . Ann Biomed Eng 2012;40(6):1228-43.
  • 38. Kirby BJ. Nanofluidics: fluid and current flow in molecular-scale and thick-EDL systems. In: Kirby BJ, ed. Micro- and Nanoscale Fluid Mechanics: Transport in Microfluidic Devices. 1st ed. Cambridge: Cambridge University Press; 2010. p.336-44.
  • 37. Chokkalingam V, Weidenhof B, Krämer M, Maier WF, Herminghaus S, Seemann R. Optimized droplet-based microfluidics scheme for sol-gel reactions. Lab Chip 2010;10(13):1700-5.
  • 36. Piersma AH. Alternative methods for developmental toxicity testing. Basic Clin Pharma col Toxicol 2006;98(5):427-31.
  • 35. Brunner D , Frank J , Appl H, Schö ffl H, Pf aller W, Gstraunthaler G. Serum-free cell culture: the serum-free m edia interactiv e on line data base. ALTEX 2010;27(1):53-62.
  • 34. Xu KP, Li XF, Yu FS. Corneal organ culture model for assessing epithelial responses to surfactants. Toxicol Sci 2000;58(2):306-14.
  • 33. Steinhoff G, Stock U, Karim N,Mertsching H, Timke A, Meliss RR, et al. Tissue engineering of pulmonaryheart valves on allogenic acellular matrix conduits in vivo restoration of valve tiss ue. Circulation 2000;102(19 Suppl 3):III50-5.
  • 32. Shay JW, Wright WE. The use of telomerized cells for tissue engineering. Nat Biotechnol 2000;18(1):22-3.
  • 31. Pizzoferrato A, Ciapetti G, Stea S, CenniE, Arciola CR, Granchi D, et al. Cell culture methods for testing bio-compatibility. Clin Mater 1994;15(3):173-90.
  • 30. Saka VP, Srinivasababu P, Himaja V, Bhagawathi V, Prasannanjaneyulu P, Rao YV, et al.Review on alter-native to testing animals. Int J Ad van Pharm Sci 2016;7(2):3050-3.
  • 29. Emerson M. Refinement, reduction and replacement approaches to in vivo cardiovascular research. Br J Pharmacol 2010;161(4): 749-54.
  • 28. Kimber I, Pichowski JS, Betts CJ, Cumberbatch M, Basketter DA, Dearman RJ. Alternative approaches to the identification and characterization of chemical al-lergens. Toxicol In Vitro 2001;15(4-5):307-12.
  • 27. Foreman DM, Pancholi S, Jarvis-Evans J, McLeod D, Boulton ME. A simple organ culture model for assess-ing the effects of growth factor on corneal re-epitheli-azation. Exp Eye Res 1996;62(5):555-64.
  • 26. Melikoglu Golcu B, Aksoy A. [An overview of legisla-tion on the use of experimental animals in the euro-pean union and Turkey]. Turkiye Klinikleri J Lab Anim 2017;1(1):56-62.
  • 25. Schechtman LM. Implementation of the 3Rs (refine-ment, reduction, and replacement): validation and reg-ulatory acceptance cons iderations f or al ternative toxicological t est met hods. I LAR J 2002; 43 Supp l 1:S85-94.
  • 24. Pereira S, Tettamanti M. Ahimsa and alternatives--the concept of the 4th R. The CPCSEA in India. ALTEX 2005;22(1):3-6.
  • 23. Banks RE. The 4th R of research. Contemp Top Lab Anim Sci 1995;34(1):50-1.
  • 22. Russell WMS, Burch RL. The Principles of Humane Experimental Technique. 1st ed. London: Methuen; 1959. p.238.
  • 21. Sharma S, Bhatt M, Dahiya N, Gupta AK, Bras hier DBS, Sharma AK. Alternatives to animalexperiments: an overview. AsianJ Pharm Toxicol 2015;3(7):16-.
  • 20. Flecknell PA. Refinement of animal use--assessment and alleviation o f pai n and dis tress. Lab Anim 1994;28(3):222-31.
  • 19. Arora T, Mehta AK, Josh i V, Mehta KD, Ra thor N, Mediratta PK, et al. Substitute of animals in drug re-search: an approach towards fulfilmentof 4R’s. Indian J Pharm Sci 2011;73(1):1-6.
  • 18. Balls M. Replacement of animal procedures: alterna-tives in research, educati on and testi ng. Lab Anim 1994;28(3):193-211.
  • 17. Rollin BE. Toxicology andnew social ethicsfor animals. Toxicol Pathol 2003;31 Suppl: 128-31.
  • 16. Rusche B. The 3Rs and animal welfare-conflict or the way forward? ALTEX 2003; 20(Suppl 1):63-76.
  • 15. Baumans V. Science-based assessment of animal wel-fare: laboratory animals. RevSci Tech 2005;24(2):503-13.
  • 14. Doke SK, Dhawale SC. Alternatives to animal testing: a review. Saudi Pharm J 2015;23(3): 223-9.
  • 13. Izmirli S, Aldavood SJ, Yasar A, Phillips CJ. Introducing ethical evaluation of the use of animals in experiments in the Near East. Altern Lab Anim 2010;38(4):331-6.
  • 12. Max-Planck-Gesellschaft. Ani mal research in Ger - many. https://www.mpg.de/animal-studies- portal/ani-mal-research Accessed: December 13, 2017.
  • 11. Leary SA. The exclusion of mice, rats, and birds. The Animal Welfare Act At 50; 2017. p.2. http://aavs.org/as-sets/uploads/2017/ 08/2017-1_av-magazine_exclusion-mice-rats-birds.pdf?x82509. Accessed: January 15, 2018.
  • 10. USDA. Annual Report Animal Usage by Fiscal Year: 2016. United State Department of Agriculture. Animal and Plant Health Inspection Service; 2017. p.10. June 27, 2017. https: //www.aphis.usda.gov/animal_wel-fare/downloads/reports/Annual-Report-Animal-Usage-by-FY2016.pdf. Accessed: December 13, 2017.
  • 9. Great Britain Home Office. Annual Statistics of Scientific Procedures on Living Animals Great Britain 2016. p.57. https://www.gov.uk/ government/uploads/system/uploads/attachment_data/file/627284/annual-statistics-scientific-procedures-living-animals-2016.pdf. Accessed: November 21, 2017.
  • 8. EC. Report from the commission to the council and the european parliament. Sixth Report on the Statistics on the Number of Animals used for Experimental and other Scientific Purposes in the Member States of the European Union SEC 1107. Brussels; 2010. 8.12.2010.
  • 7. Knight A. The beginning of the end for chimpanzee experiments? Philos Ethics Humanit Med 2008;3(1):16.
  • 6. Taylor K, Gordon N, Langley G, Higgins W. Estimates for worldwide laboratory animal use in 2005. Altern Lab Anim 2008;36(3):327-42.
  • 5. Hendriksen CF. Replacement, reduction and refinement alternatives to animal use in vaccine potency measurement. Expert Rev Vaccines 2009;8(3):31322.
  • 4. Hendriksen CF. Three Rs achievements in vaccinology. AATEX 2007;14:575-9.
  • 3. Giacomotto J, Ségalat L. High-throughput screening and small animal models, where are we? Br J Pharmacol 2010;160(2):204-16.
  • 2. Franco NH. Animal experiments in biomedical research: a historical perspective. Animals (Basel) 2013;3(1):238-73.
  • 1. CULABBR. Use of laboratory animals in biomedical and behavioral research. Committee on Use of Laboratory Animals in Biomedical and Behavioral Research. National Research Council and Institute of Medicine. 1sted. Washington, DC: National Academy Press; 1998. p.12-5.
APA Mushtaq S, DAŞ Y, Aksoy A (2018). Alternative Methods to Animal Experiments. , 161 - 170. 10.5336/medsci.2018-59993
Chicago Mushtaq Saima,DAŞ Yavuz Kürşat,Aksoy Abdurrahman Alternative Methods to Animal Experiments. (2018): 161 - 170. 10.5336/medsci.2018-59993
MLA Mushtaq Saima,DAŞ Yavuz Kürşat,Aksoy Abdurrahman Alternative Methods to Animal Experiments. , 2018, ss.161 - 170. 10.5336/medsci.2018-59993
AMA Mushtaq S,DAŞ Y,Aksoy A Alternative Methods to Animal Experiments. . 2018; 161 - 170. 10.5336/medsci.2018-59993
Vancouver Mushtaq S,DAŞ Y,Aksoy A Alternative Methods to Animal Experiments. . 2018; 161 - 170. 10.5336/medsci.2018-59993
IEEE Mushtaq S,DAŞ Y,Aksoy A "Alternative Methods to Animal Experiments." , ss.161 - 170, 2018. 10.5336/medsci.2018-59993
ISNAD Mushtaq, Saima vd. "Alternative Methods to Animal Experiments". (2018), 161-170. https://doi.org/10.5336/medsci.2018-59993
APA Mushtaq S, DAŞ Y, Aksoy A (2018). Alternative Methods to Animal Experiments. Türkiye Klinikleri Tıp Bilimleri Dergisi, 38(2), 161 - 170. 10.5336/medsci.2018-59993
Chicago Mushtaq Saima,DAŞ Yavuz Kürşat,Aksoy Abdurrahman Alternative Methods to Animal Experiments. Türkiye Klinikleri Tıp Bilimleri Dergisi 38, no.2 (2018): 161 - 170. 10.5336/medsci.2018-59993
MLA Mushtaq Saima,DAŞ Yavuz Kürşat,Aksoy Abdurrahman Alternative Methods to Animal Experiments. Türkiye Klinikleri Tıp Bilimleri Dergisi, vol.38, no.2, 2018, ss.161 - 170. 10.5336/medsci.2018-59993
AMA Mushtaq S,DAŞ Y,Aksoy A Alternative Methods to Animal Experiments. Türkiye Klinikleri Tıp Bilimleri Dergisi. 2018; 38(2): 161 - 170. 10.5336/medsci.2018-59993
Vancouver Mushtaq S,DAŞ Y,Aksoy A Alternative Methods to Animal Experiments. Türkiye Klinikleri Tıp Bilimleri Dergisi. 2018; 38(2): 161 - 170. 10.5336/medsci.2018-59993
IEEE Mushtaq S,DAŞ Y,Aksoy A "Alternative Methods to Animal Experiments." Türkiye Klinikleri Tıp Bilimleri Dergisi, 38, ss.161 - 170, 2018. 10.5336/medsci.2018-59993
ISNAD Mushtaq, Saima vd. "Alternative Methods to Animal Experiments". Türkiye Klinikleri Tıp Bilimleri Dergisi 38/2 (2018), 161-170. https://doi.org/10.5336/medsci.2018-59993